StemRIM is a biotechnology company
aiming to develop a next generation of regenerative medicine,
"Regeneration-inducing Medicine" is an innovative new class of medicine that induces functional regeneration of tissues and organs in the patient's body by maximizing the human body's innate ability of tissue repairing.
We are pursuing research and development of new drugs based on a novel mechanism of action leading to recruitment of the patients’ own in-vivo stem cells to the damaged tissues for functional tissue regeneration without conventional cell-therapy approaches.
The origin of the company name of StemRIM is "Stem cell Regeneration-Inducing Medicine".